According to GlobalData, QUANTIVIRUS is one of 160 product lines sold in the US respiratory disease tests market; these product lines are sold by 75 different manufacturers. The price of the QUANTIVIRUS device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as DiaCarta apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
DiaCarta Inc (DiaCarta) is a developer of molecular diagnostics products for cancer and infectious diseases. The company offers genomic testing for biomarkers and also provides clinical sample testing services in their CLIA-certified lab. It offers products such as gene mutation detection kits, colon cancer tests, fusion gene detection tests, adapter dimer removal, DNA sample card, CRISPR gene editing, PCR ready lysis buffers and genotyping tests, among others. DiaCarta provides services including CLIA lab services; NGS target sequencing, next generation sequencing, companion diagnostics and CAR-T immunotherapy. The company markets its products through a channel of network distributors. It serves in Germany, Egypt, Iran, Turkey, Iraq and Costa Rica. DiaCarta is headquartered in Richmond, California, The US.
For a complete picture of QUANTIVIRUS, Respiratory Disease Tests pricing in the US, buy the report here.